ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,006Medicare Part D Prescriptions Filled, Including Refills

Rank: 190 out of 2094

$628K Total Retail Price of All Prescriptions

Rank: 320 out of 2094

289 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 289 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 289 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 9,737 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 342 336 1 3
SERTRALINE HCL 336 333 2 26
FUROSEMIDE 305 289 3 6
SIMVASTATIN 275 267 4 1
WARFARIN SODIUM 258 195 5 11
OMEPRAZOLE 256 256 6 4
METOPROLOL TARTRATE 239 239 7 10
DONEPEZIL HCL 222 222 8 20
AMLODIPINE BESYLATE 213 213 9 2
POLYETHYLENE GLYCOL 3350 197 191 10 75
METOPROLOL SUCCINATE 160 159 11 9
LISINOPRIL 159 155 12 7
PREDNISONE 149 138 13 54
LACTULOSE 145 145 14 65
ATENOLOL 136 136 15 21
ATORVASTATIN CALCIUM 133 129 16 5
CARBIDOPA-LEVODOPA 130 130 17 102
NAMENDA 120 120 18 32
GABAPENTIN 117 105 19 23
HYDROCHLOROTHIAZIDE 108 106 20 12
MIRTAZAPINE 106 106 21 43
PAROXETINE HCL 97 97 22 77
HUMALOG 95 95 23 164
ZOLPIDEM TARTRATE 95 94 23 14
POTASSIUM CHLORIDE 94 94 25 24
CLOPIDOGREL 92 92 26 22
FENTANYL 87 87 S2 27 68
HYDROCODONE-ACETAMINOPHEN 86 86 S3 28 42
LANTUS 82 82 29 66
ESCITALOPRAM OXALATE 80 80 30 46
LOSARTAN POTASSIUM 80 77 30 17
DIVALPROEX SODIUM 78 78 32 69
RISPERIDONE 77 77 33 56
TAMSULOSIN HCL 76 75 34 29
DIOVAN 75 75 35 13
FLUTICASONE PROPIONATE 74 72 36 41
ISOSORBIDE MONONITRATE ER 72 72 37 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 70 38 55
CITALOPRAM HBR 71 71 38 47
METFORMIN HCL 63 63 40 8
NEXIUM 61 59 41 16
SPIRIVA 59 59 42 60
CARVEDILOL 58 58 43 19
TRAMADOL HCL 55 51 44 33
FAMOTIDINE 55 55 44 34
PLAVIX 54 54 46 38
CREON 54 54 46 219
QUETIAPINE FUMARATE 52 52 48 71
ENALAPRIL MALEATE 52 52 48 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.